| Longitudinal analysis of impulse control disorders in Parkinson disease JC Corvol, F Artaud, F Cormier-Dequaire, O Rascol, F Durif, ... Neurology 91 (3), e189-e201, 2018 | 226 | 2018 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 80 | 2021 |
| Central pain modulation after subthalamic nucleus stimulation: a crossover randomized trial A Marques, O Chassin, D Morand, B Pereira, B Debilly, P Derost, M Ulla, ... Neurology 81 (7), 633-640, 2013 | 80 | 2013 |
| Hallucinations in schizophrenia and Parkinson’s disease: an analysis of sensory modalities involved and the repercussion on patients PM Llorca, B Pereira, R Jardri, I Chereau-Boudet, G Brousse, D Misdrahi, ... Scientific reports 6 (1), 1-9, 2016 | 77 | 2016 |
| Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder ML Fantini, L Macedo, M Zibetti, M Sarchioto, T Vidal, B Pereira, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (2), 174-179, 2015 | 74 | 2015 |
| REM sleep behaviour disorder and visuoperceptive dysfunction: a disorder of the ventral visual stream? A Marques, K Dujardin, M Boucart, D Pins, M Delliaux, L Defebvre, ... Journal of neurology 257, 383-391, 2010 | 73 | 2010 |
| Trial of deferiprone in Parkinson’s disease D Devos, J Labreuche, O Rascol, JC Corvol, A Duhamel, ... New England Journal of Medicine 387 (22), 2045-2055, 2022 | 72 | 2022 |
| A phase 1 randomized trial of specific active α‐synuclein immunotherapies PD01A and PD03A in multiple system atrophy WG Meissner, APL Traon, A Foubert‐Samier, G Galabova, M Galitzky, ... Movement Disorders 35 (11), 1957-1965, 2020 | 59 | 2020 |
| Body weight gain and deep brain stimulation I Rieu, P Derost, M Ulla, A Marques, B Debilly, I De Chazeron, I Chéreau, ... Journal of the neurological sciences 310 (1-2), 267-270, 2011 | 59 | 2011 |
| Glucose dysregulation in Parkinson's disease: Too much glucose or not enough insulin? A Marques, F Dutheil, E Durand, I Rieu, A Mulliez, ML Fantini, Y Boirie, ... Parkinsonism & related disorders 55, 122-127, 2018 | 54 | 2018 |
| Are there differences between cephalic and extracephalic cutaneous allodynia in migraine patients? N Guy, AR Marques, T Orliaguet, M Lanteri-Minet, R Dallel, P Clavelou Cephalalgia 30 (7), 881-886, 2010 | 54 | 2010 |
| Comparison between automatic and visual scorings of REM sleep without atonia for the diagnosis of REM sleep behavior disorder in Parkinson disease M Figorilli, R Ferri, M Zibetti, P Beudin, M Puligheddu, L Lopiano, ... Sleep 40 (2), zsw060, 2017 | 51 | 2017 |
| A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data G Pagano, FG Boess, KI Taylor, B Ricci, B Mollenhauer, W Poewe, ... Frontiers in neurology 12, 705407, 2021 | 50 | 2021 |
| Sleep and REM sleep behaviour disorder in Parkinson’s disease with impulse control disorder ML Fantini, M Figorilli, I Arnulf, M Zibetti, B Pereira, P Beudin, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (3), 305-310, 2018 | 47 | 2018 |
| Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial I Rieu, B Degos, G Castelnovo, C Vial, E Durand, B Pereira, ... Parkinsonism & Related Disorders 46, 9-15, 2018 | 40 | 2018 |
| Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised … VC De Cock, P Dodet, S Leu-Semenescu, C Aerts, G Castelnovo, B Abril, ... The Lancet Neurology 21 (5), 428-437, 2022 | 39 | 2022 |
| Examining the reserve hypothesis in Parkinson's disease: a longitudinal study PC Lee, F Artaud, F Cormier‐Dequaire, O Rascol, F Durif, P Derkinderen, ... Movement Disorders 34 (11), 1663-1671, 2019 | 36 | 2019 |
| Impulse control disorders in Parkinson’s disease A Marques, F Durif, PO Fernagut Journal of neural transmission 125, 1299-1312, 2018 | 36 | 2018 |
| Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation? A Marques, ML Fantini, D Morand, B Pereira, P Derost, M Ulla, B Debilly, ... Sleep Medicine 16 (5), 583-588, 2015 | 36 | 2015 |
| In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study R Lorusso, ME De Piero, S Mariani, M Di Mauro, T Folliguet, FS Taccone, ... The Lancet Respiratory Medicine 11 (2), 151-162, 2023 | 35 | 2023 |
Maria Livia FantiniUniversité Clermont-AuvergneVerified email at chu-clermontferrand.fr
